Immediate Impact

6 by Nobel laureates 5 from Science/Nature 67 standout
Sub-graph 1 of 23

Citing Papers

Transferrin receptor targeting chimeras for membrane protein degradation
2024 StandoutNature
Overall survival with sacituzumab govitecan in hormone receptor-positive and human epidermal growth factor receptor 2-negative metastatic breast cancer (TROPiCS-02): a randomised, open-label, multicentre, phase 3 trial
2023 Standout
2 intermediate papers

Works of Dave Shelton being referenced

RN927C, a Site-Specific Trop-2 Antibody–Drug Conjugate (ADC) with Enhanced Stability, Is Highly Efficacious in Preclinical Solid Tumor Models
2016
Increasing Serum Half-life and Extending Cholesterol Lowering in Vivo by Engineering Antibody with pH-sensitive Binding to PCSK9
2012

Author Peers

Author Last Decade Papers Cites
Dave Shelton 43 154 82 168 10 428
Daniel Binder 21 43 45 100 19 504
Edward N. Martin 10 125 13 104 18 460
Jay B. Horowitz 7 40 77 60 9 426
Wing-Yiu Jason Lee 8 48 39 149 10 483
Kathryn Wareham 26 32 15 103 11 397
Catherine Schaffner 9 29 33 122 6 500
Stephanie Kim 5 48 24 238 17 482
Heather E. Lynch 10 30 41 102 9 494
Fumi Mineshiba 34 29 46 152 17 387
Mengxing Sun 18 135 26 168 14 389

All Works

Loading papers...

Rankless by CCL
2026